LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/How Representative is the AAOS Joint Replacement Registry?
Large Joints and Extremities

How Representative is the AAOS Joint Replacement Registry?

October 20, 2021 2 min read Premium comments

Advertisement

#totalkneearthroplasty#aaosSecondary#ajrr

Garbage in, Garbage out.  That is the #1 risk of any dataset, data stream or registry.  Now that the AAOS Joint Replacement Registry (AJRR) has become the nation’s largest such repository of joint surgery data, how representative is it in terms of national demographics, inpatient utilization, access, cost, quality, and outcomes?

A new study titled “Is American Joint Replacement Registry Data Representative of National Data? A Comparative Analysis,” has just been published in the August 25, 2021, edition of The Journal of the American Academy of Orthopaedic Surgeons.

OTW spoke with the study authors, and they explained that “generalizability (or external validity) is crucial for measuring how applicable findings and conclusions from a sample are to the cohort at large.”  To determine the external validity of the American Joint Registry data, the authors collected AJRR data for all patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA) between 2012 to 2018 and then compared that to similar data between 2012 to 2016 in the National Inpatient Sample dataset.

The team looked for differences between the two databases and measured the magnitude of those differences in terms of demographics, hospital volume, and geographic characteristics.

Co-author James I. Huddleston, III, M.D., vice chair of the AJRR Steering Committee and an orthopedic surgeon at Stanford Health Care, explained to OTW that the team “needed to allow the AJRR to mature to the point where there were enough data to represent a ‘national’ sample.”  And mature it did. According to the study authors, as of October 1, 2020, the AJRR includes over 2.1 million hip and knee arthroplasty procedures (more than 1,400 medical institutions and 11,000 surgeons.)

For this work, the authors analyzed:

  • 2,316,345 primary THA’s from the National Inpatient Sample
  • 557,684 THA’s from the AJRR
  • 3,417,700 TKAs from the National Inpatient Sample
  • 809,494 TKAs from the AJRR

They found that the proportions of AJRR and National Inpatient Sample patients were similar based on overall sex, small differences were identified between databases considering hospital volume and geography.

“The AJRR was underrepresented in Southern regions and hospitals with low procedure volume and overrepresented in Northern hospitals and those with larger volume. Both the National Inpatient Sample and the AJRR followed a similar overall trend, with most procedures performed at hospitals with <50 cases per year,” wrote the authors.

“When compared to the Nationwide Inpatient Sample,” said Dr. Huddleston to OTW, “the AJRR showed similar hospital volumes, patient ages, and geography. This comparison supports the generalizability of AJRR data to a larger national sample.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy